Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today
December 02 2009 - 12:00AM
PR Newswire (US)
SAN DIEGO, Dec. 2 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated
(NASDAQ:GPRO) will present at the 21st Annual Piper Jaffray Health
Care Conference today at 2:30 p.m. Eastern Time. The presentation
is scheduled to be webcast live and may be accessed through a link
on the investors section of Gen-Probe's website at
http://www.gen-probe.com/. The webcast will be available for 30
days following the event. About Gen-Probe Gen-Probe Incorporated is
a global leader in the development, manufacture and marketing of
rapid, accurate and cost-effective nucleic acid tests (NATs) that
are used primarily to diagnose human diseases and screen donated
human blood. Gen-Probe has approximately 25 years of NAT expertise,
and received the 2004 National Medal of Technology, America's
highest honor for technological innovation, for developing NAT
assays for blood screening. Gen-Probe is headquartered in San Diego
and employs approximately 1,200 people. For more information, go to
http://www.gen-probe.com/. Caution Regarding Forward-Looking
Statements Any statements in this press release about our
expectations, beliefs, plans, objectives, assumptions or future
events or performance are not historical facts and are
forward-looking statements. Forward-looking statements are not
guarantees of performance. They involve known and unknown risks,
uncertainties and assumptions that may cause actual results, levels
of activity, performance or achievements to differ materially from
those expressed or implied. For information about risks and
uncertainties we face and a discussion of our financial statements
and footnotes, see documents we have filed with the SEC, including
our most recent Form 10-Q, and all subsequent periodic filings made
with the SEC. We assume no obligation and expressly disclaim any
duty to update any forward-looking statement to reflect events or
circumstances after the date of this press release or to reflect
the occurrence of unanticipated events. Contact: -------- Paula
Izidoro Investor Relations 858-410-8904 DATASOURCE: Gen-Probe
Incorporated CONTACT: Paula Izidoro, Investor Relations of
Gen-Probe Incorporated, +1-858-410-8904 Web Site:
http://www.gen-probe.com/
Copyright